Is family history sufficient to identify women with risk of venous thromboembolism before commencing the contraceptive pill?

Clinical and Applied Thrombosis/Hemostasis

Volumn 8, Issue 2, 2002, Pages 139-141

  Aznar, Justo ^a   Mira, Yolanda ^a   Vayá, Amparo ^a   Ferrando, Fernando ^a   Villa, Piedad ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Family history; Oral contraceptives; Venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; ORAL CONTRACEPTIVE AGENT; PROTEIN C; PROTEIN S; PROTHROMBIN;

ACNE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DYSMENORRHEA; FAMILY HISTORY; FEMALE; GENETIC RISK; GENETIC SCREENING; HIRSUTISM; HUMAN; OVARY CYST; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; THROMBOEMBOLISM; THROMBOPHILIA; TREATMENT CONTRAINDICATION; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG CONTRAINDICATION; FAMILY HEALTH; VEIN THROMBOSIS;

CONTRACEPTIVES, ORAL; FAMILY HEALTH; FEMALE; HUMANS; QUESTIONNAIRES; RISK FACTORS; THROMBOEMBOLISM; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 0035992663     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960200800209     Document Type: Article

References (5)

1. Increased risk of venous thrombosis in oral contraceptive users who are carriers of factor V Leiden mutation
2. Selective screening for the factor V Leiden mutation: Is it advisable prior to the prescription of oral contraceptives?
3. Factor V Leiden: Should we screen oral contraceptive users and pregnant women?
4. Validated questionnaire for the identification of previous personal or familial venous thromboembolism
5. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives